NEW YORK STATE COMMON RETIREMENT FUND - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 129 filers reported holding DENALI THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 258.00 and the average weighting 1.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,679
-27.9%
129,853
+3.1%
0.00%
-20.0%
Q2 2023$3,715
+19.5%
125,899
-6.7%
0.01%
+25.0%
Q1 2023$3,108
-26.0%
134,894
-10.6%
0.00%
-33.3%
Q4 2022$4,198
-99.9%
150,954
+4.2%
0.01%0.0%
Q3 2022$4,447,000
+7.3%
144,905
+2.9%
0.01%
+20.0%
Q2 2022$4,145,000
-4.4%
140,829
+4.4%
0.01%0.0%
Q1 2022$4,338,000
-27.8%
134,841
+0.0%
0.01%
-16.7%
Q4 2021$6,012,000
-24.0%
134,787
-14.1%
0.01%
-25.0%
Q3 2021$7,915,000
-44.0%
156,893
-13.0%
0.01%
-46.7%
Q2 2021$14,140,000
+68.6%
180,261
+22.7%
0.02%
+66.7%
Q1 2021$8,388,000
-27.1%
146,903
+7.0%
0.01%
-30.8%
Q4 2020$11,500,000
+305.8%
137,298
+73.6%
0.01%
+333.3%
Q3 2020$2,834,000
+103.4%
79,100
+37.3%
0.00%
+50.0%
Q2 2020$1,393,000
+86.0%
57,600
+34.6%
0.00%
+100.0%
Q1 2020$749,000
+0.4%
42,8000.0%0.00%0.0%
Q4 2019$746,000
-1.8%
42,800
-13.7%
0.00%0.0%
Q3 2019$760,000
-26.2%
49,6000.0%0.00%0.0%
Q2 2019$1,030,000
-23.3%
49,600
-14.2%
0.00%
-50.0%
Q1 2019$1,343,000
+45.3%
57,820
+29.4%
0.00%
+100.0%
Q4 2018$924,000
+104.4%
44,700
+114.9%
0.00%0.0%
Q3 2018$452,000
+42.6%
20,8000.0%0.00%
Q2 2018$317,000
+83.2%
20,800
+136.4%
0.00%
Q1 2018$173,0008,8000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$298,165,00048.02%
Bratton Capital Management, L.P. 953,035$14,600,00028.53%
Flagship Pioneering Inc. 8,005,747$122,648,0006.71%
Casdin Capital, LLC 650,000$9,958,000,0001.03%
Temasek Holdings (Private) Ltd 4,410,457$67,568,0000.50%
MARK ASSET MANAGEMENT LP 68,864$1,055,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,507$345,0000.26%
Artal Group S.A. 400,000$6,128,0000.25%
PIER 88 INVESTMENT PARTNERS LLC 40,610$622,0000.24%
HAMILTON LANE ADVISORS LLC 30,948$474,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders